Considering the efficacy of monoclonal antibodies (mAbs) directed against the Spike (S)
protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in reducing …

Introduction Considering the reported efficacy of monoclonal antibodies (mAbs) directed
against the Spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS …

Our aim was to analyze severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-
specific antibody level kinetics after coronavirus disease 2019 (COVID-19) infection and …

At the end of 2020, population-based vaccination programs with new generation mRNA-
based vaccines began almost all over the world. The aim of the study was to evaluate the …

Objectives We assessed vaccination-induced antibody and cellular responses against spike
from the ancestral strain and from the delta (δ) SARS-CoV-2 variant in patients with immune …

Background: Viral infections including SARS-CoV-2 are controlled by cell-mediated and
humoral immune responses. Vaccination against SARS-CoV-2 induces a rapid and long …

Introduction The induction and speed of production of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) immune biomarkers may vary by type and number of …

The SARS‐CoV‐2 virus was detected for the first time in December 2019 in Wuhan, China.
Currently, this virus has spread around the world, and new variants have emerged. This new …

There is an ongoing need for high-precision serological assays for the quantitation of anti-
SARS-CoV-2 antibodies. Here, a trimeric SARS-CoV-2 spike (S) protein was used to …

For the assessment of vaccine-induced immune response and to understand the role of
antibodies in neutralization, it is necessary to assess dynamics of various antibodies in …